RenovoRx Announces JonesTrading Webinar Participation on Aug 13, 2026

What Happened
RenovoRx, Inc. (RNXT) filed an 8-K on August 4, 2026 announcing that it will participate in a JonesTrading key opinion leader webinar focused on pancreatic cancer and the company’s technology platform. The webinar is scheduled for August 13, 2026. The company issued a press release dated August 4, 2026, which was attached to the filing as Exhibit 99.1.

Key Details

• 8-K filed: August 4, 2026.
• Event: JonesTrading key opinion leader webinar covering pancreatic cancer and RenovoRx’s technology platform.
• Webinar date: August 13, 2026.
• Press release announcing the participation included as Exhibit 99.1 in the 8-K filing.

Why It Matters
This filing signals investor and industry outreach—RenovoRx is presenting its pancreatic cancer work and platform to a targeted audience of analysts, investors, and key opinion leaders. For investors, such events can raise awareness of the company’s clinical programs and technology, potentially affecting market visibility and interest. The 8-K does not report financial results, management changes, or operational milestones beyond the announced webinar.